J&J Settles Texas' Risperdal Suit For $158M
A Johnson & Johnson unit will pay $158 million to settle claims by the state of Texas that it illegally marketed antipsychotic drug Risperdal, the company announced Thursday....To view the full article, register now.
Already a subscriber? Click here to view full article